{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:37:42Z","timestamp":1793299062311,"version":"4.5.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejogrb.2024.07.042","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T01:51:53Z","timestamp":1721613113000},"page":"268-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Does the use of angiogenic biomarkers for the management of preeclampsia and fetal growth restriction improve outcomes?: Challenging the current status quo"],"prefix":"10.1016","volume":"300","author":[{"given":"Ruben","family":"Ramirez Zegarra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tullio","family":"Ghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2024.07.042_b0005","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.119.13763","article-title":"Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome","volume":"75","author":"Stepan","year":"2020","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0010","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1471-0528.1972.tb12922.x","article-title":"On the pathogenesis of placental infarcts in pre-eclampsia","volume":"79","author":"Brosens","year":"1972","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0015","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1471-0528.1986.tb07830.x","article-title":"Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants","volume":"93","author":"Khong","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0020","first-page":"1061","article-title":"Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study","volume":"76","author":"Easterling","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejogrb.2013.03.016","article-title":"Characteristics of heart, arteries, and veins in low and high cardiac output preeclampsia","volume":"169","author":"Tomsin","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0030","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/uog.5311","article-title":"Maternal cardiac function in normotensive and pre-eclamptic intrauterine growth restriction","volume":"32","author":"Bamfo","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0035","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/HYPERTENSIONAHA.108.117358","article-title":"Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease","volume":"52","author":"Valensise","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0040","article-title":"An update on maternal cardiac hemodynamics in fetal growth restriction and pre-eclampsia","author":"Dall\u2019Asta","year":"2022","journal-title":"J Clin Ultrasound"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0045","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.118.11092","article-title":"Association between prepregnancy cardiovascular function and subsequent preeclampsia or fetal growth restriction","volume":"72","author":"Foo","year":"2018","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0050","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra2109523","article-title":"Preeclampsia","volume":"386","author":"Magee","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0055","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0060","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/10641955.2016.1190846","article-title":"Preeclampsia and preterm delivery: a population-based case-control study","volume":"35","author":"Davies","year":"2016","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajog.2019.11.1247","article-title":"The competing risk approach for prediction of preeclampsia","volume":"223","author":"Wright","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0070","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/1471-0528.14029","article-title":"The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review","volume":"123","author":"Al-Rubaie","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/uog.24789","article-title":"STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35\u201337 weeks\u2019 gestation","volume":"59","author":"D\u00f6bert","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0085","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/uog.15997","article-title":"sFlt-1\/PlGF ratio test for pre-eclampsia: an economic assessment for the UK","volume":"48","author":"Vatish","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0090","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 international society for the study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0095","unstructured":"NICE. PLGF-based testing to help diagnose suspected preterm pre-eclampsia. Diagnostics guidance [DG49] 2022. https:\/\/www.nice.org.uk\/guidance\/dg49 (accessed September 1, 2023)."},{"key":"10.1016\/j.ejogrb.2024.07.042_b0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/uog.26032","article-title":"Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction","volume":"61","author":"Stepan","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0105","doi-asserted-by":"crossref","first-page":"S1222","DOI":"10.1016\/j.ajog.2020.08.018","article-title":"Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension","volume":"226","author":"Scott","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0110","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"ACOG practice bulletin, Number 222","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0115","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","article-title":"Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial","volume":"393","author":"Duhig","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clp.2007.11.001","article-title":"Medically indicated preterm birth: recognizing the importance of the problem","volume":"35","author":"Ananth","year":"2008","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jamapediatrics.2017.5323","article-title":"Cognitive outcomes of children born extremely or very preterm since the 1990s and associated risk factors: a meta-analysis and meta-regression","volume":"172","author":"Twilhaar","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0130","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(14)61998-X","article-title":"Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial","volume":"385","author":"Broekhuijsen","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0135","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0140-6736(19)31963-4","article-title":"Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial","volume":"394","author":"Chappell","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0140","first-page":"1122","article-title":"Report of the American college of obstetricians and gynecologists\u2019 task force on hypertension in pregnancy","volume":"122","author":"Hypertension in pregnancy","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.preghy.2018.05.008","article-title":"Angiogenic biomarkers in triage and risk for preeclampsia with severe features","volume":"13","author":"Rana","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0150","doi-asserted-by":"crossref","first-page":"573.e1","DOI":"10.1016\/j.ajog.2022.10.044","article-title":"The additive role of angiogenic markers for women with confirmed preeclampsia","volume":"228","author":"Suresh","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0155","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/uog.17561","article-title":"Prediction of severe pre-eclampsia\/HELLP syndrome by combination of sFlt-1, CT-pro-ET-1 and blood pressure: exploratory study","volume":"51","author":"Lind Malte","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0160","doi-asserted-by":"crossref","first-page":"e015548","DOI":"10.1161\/JAHA.119.015548","article-title":"Maternal and perinatal outcomes associated with extremely high values for the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PLGF (placental growth factor) ratio","volume":"9","author":"Villala\u00edn","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0165","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.preghy.2018.03.013","article-title":"Placental growth factor informed management of suspected pre-eclampsia or fetal growth restriction: the MAPPLE cohort study","volume":"14","author":"Sharp","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0170","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/uog.17490","article-title":"Predicting delivery of a small-for-gestational-age infant and adverse perinatal outcome in women with suspected pre-eclampsia","volume":"51","author":"Griffin","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0175","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.preghy.2018.03.007","article-title":"A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and\/or fetal growth restriction","volume":"14","author":"Ormesher","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0180","doi-asserted-by":"crossref","first-page":"497.e1","DOI":"10.1016\/j.ajog.2022.03.064","article-title":"Placental protein levels in maternal serum are associated with adverse pregnancy outcomes in nulliparous patients","volume":"227","author":"Parry","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0185","doi-asserted-by":"crossref","first-page":"259.e1","DOI":"10.1016\/j.ajog.2019.09.003","article-title":"Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study","volume":"222","author":"Barton","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0190","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0195","doi-asserted-by":"crossref","first-page":"89.e1","DOI":"10.1016\/j.ajog.2016.01.168","article-title":"Sequential plasma angiogenic factors levels in women with suspected preeclampsia","volume":"215","author":"Baltajian","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/uog.19051","article-title":"Comparison of three commercially available placental growth factor-based tests in women with suspected preterm pre-eclampsia: the COMPARE study","volume":"53","author":"McCarthy","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/AOG.0000000000001525","article-title":"Soluble fms-like tyrosine kinase-1-to-placental growth factor ratio and time to delivery in women with suspected preeclampsia","volume":"128","author":"Zeisler","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0210","first-page":"10","article-title":"Adverse neonatal outcome of pregnancies complicated by preeclampsia","author":"Tousty","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0215","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/HYPERTENSIONAHA.118.12205","article-title":"Angiogenic factor estimation as a warning sign of preeclampsia-related peripartum morbidity among hospitalized patients","volume":"73","author":"Lopes Perdigao","year":"2019","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0220","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.117.09913","article-title":"Angiogenic markers predict pregnancy complications and prolongation in preeclampsia: continuous versus cutoff values","volume":"70","author":"Saleh","year":"2017","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0225","article-title":"Placental growth factor in assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a stepped wedge cluster randomised control trial (PARROT Ireland)","volume":"374","author":"Hayes-Ryan","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0230","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.122.20361","article-title":"PREPARE: A stepped-wedge cluster-randomized trial to evaluate whether risk stratification can reduce preterm deliveries among patients with suspected or confirmed preterm preeclampsia","author":"De Oliveira","year":"2023","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0235","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","article-title":"Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model","volume":"377","author":"von Dadelszen","year":"2011","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0240","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1089\/whr.2021.0141","article-title":"Spin in randomized controlled trials in obstetrics and gynecology: A systematic review","volume":"3","author":"Chow","year":"2022","journal-title":"Women\u2019s Heal Reports (New Rochelle, NY)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0245","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/AOG.0000000000001818","article-title":"It\u2019s all how you \u201cspin\u201d it: interpretive bias in research findings in the obstetrics and gynecology literature","volume":"129","author":"Turrentine","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0250","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","article-title":"Randomized interventional study on prediction of preeclampsia\/eclampsia in women with suspected preeclampsia: INSPIRE","volume":"74","author":"Cerdeira","year":"2019","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0255","doi-asserted-by":"crossref","first-page":"e076201","DOI":"10.1136\/bmjopen-2023-076201","article-title":"Multicentre randomised trial of screening with sFlt1\/PlGF and planned delivery to prevent pre-eclampsia at term: protocol of the PE37 study","volume":"14","author":"Llurba","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0260","article-title":"From promising biomarker to useful test: a long and winding road","volume":"166","author":"Bossuyt","year":"2022","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0265","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1515\/jpm-2012-0248","article-title":"The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome","volume":"41","author":"Schaarschmidt","year":"2013","journal-title":"J Perinat Med"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0270","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/aogs.13818","article-title":"Diagnostic accuracy of repeat placental growth factor measurements in women with suspected preeclampsia: a case series study","volume":"99","author":"Duhig","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0275","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.preghy.2022.03.009","article-title":"Longitudinal changes in angiogenesis biomarkers within 72 h of diagnosis and time-to-delivery in early-onset preeclampsia","volume":"28","author":"Villalain","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0280","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/uog.19178","article-title":"Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting","volume":"53","author":"Zeisler","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0285","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/1471-0528.16383","article-title":"Added prognostic value of longitudinal changes of angiogenic factors in early-onset severe pre-eclampsia: a prospective cohort study","volume":"128","author":"Peguero","year":"2021","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0290","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(23)02357-7","article-title":"Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial","volume":"403","author":"Hurrell","year":"2024","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0295","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/1471-0528.16425","article-title":"Placental growth factor in suspected preterm pre-eclampsia: a review of the evidence and practicalities of implementation","volume":"127","author":"Hurrell","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0300","unstructured":"National Institute for Health and Clinical Excellence (NICE). Hypertension in pregnancy: diagnosis and management 2019. https:\/\/www.nice.org.uk\/guidance\/ng133."},{"key":"10.1016\/j.ejogrb.2024.07.042_b0305","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000525717","article-title":"Mechanisms of fetal adaptation to chronic hypoxia following placental insufficiency: a review","volume":"49","author":"Ramirez Zegarra","year":"2022","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0310","doi-asserted-by":"crossref","first-page":"S855","DOI":"10.1016\/j.ajog.2017.12.004","article-title":"Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy","volume":"218","author":"McCowan","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0315","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bpobgyn.2016.10.006","article-title":"An integrated approach to fetal growth restriction","volume":"38","author":"Figueras","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0320","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"Suppl","key":"10.1016\/j.ejogrb.2024.07.042_b0325","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13522","article-title":"FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction","volume":"152","author":"Melamed","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0330","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/uog.22134","article-title":"ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction","volume":"56","author":"Lees","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0335","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/aogs.13978","article-title":"Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age","volume":"100","author":"Garcia-Manau","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0340","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/uog.13246","article-title":"Angiogenic factors vs Doppler surveillance in the prediction of adverse outcome among late-pregnancy small-for- gestational-age fetuses","volume":"43","author":"Lobmaier","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0345","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/uog.18894","article-title":"Longitudinal change of sFlt-1\/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction","volume":"52","author":"Herraiz","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0350","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/AOG.0000000000000367","article-title":"Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction","volume":"124","author":"Herraiz","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton","year":"2016","journal-title":"Placenta"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0360","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1471-0528.2008.01670.x","article-title":"Predictiveness of antenatal umbilical artery Doppler for adverse pregnancy outcome in small-for-gestational-age babies according to customised birthweight centiles: population-based study","volume":"115","author":"Figueras","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0365","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000359969","article-title":"Placental pathology in early-onset and late-onset fetal growth restriction","volume":"36","author":"Mifsud","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0370","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/ajo.12831","article-title":"Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies","volume":"59","author":"Anderson","year":"2019","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0375","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/aogs.14032","article-title":"Individual risk assessment for prenatal counseling in early-onset growth-restricted and small-for-gestational-age fetuses","volume":"100","author":"Mendoza","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0380","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(14)62049-3","article-title":"2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial","volume":"385","author":"Lees","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0385","doi-asserted-by":"crossref","first-page":"S774","DOI":"10.1016\/j.ajog.2017.11.566","article-title":"Risk of fetal death in growth-restricted fetuses with umbilical and\/or ductus venosus absent or reversed end-diastolic velocities before 34 weeks of gestation: a systematic review and meta-analysis","volume":"218","author":"Caradeux","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0390","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/uog.15729","article-title":"Value of third-trimester cerebroplacental ratio and uterine artery Doppler indices as predictors of stillbirth and perinatal loss","volume":"47","author":"Khalil","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0395","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/uog.22125","article-title":"Fetal cerebral Doppler changes and outcome in late preterm fetal growth restriction: prospective cohort study","volume":"56","author":"Stampalija","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0400","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/uog.18809","article-title":"Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcome: systematic review and meta-analysis","volume":"51","author":"Vollgraff Heidweiller-Schreurs","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0405","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/uog.14706","article-title":"Clinical utility of third-trimester uterine artery Doppler in the prediction of brain hemodynamic deterioration and adverse perinatal outcome in small-for-gestational-age fetuses","volume":"45","author":"Cruz-Martinez","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0410","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00404-021-06186-5","article-title":"Course of the sFlt-1\/PlGF ratio in fetal growth restriction and correlation with biometric measurements, feto-maternal Doppler parameters and time to delivery","volume":"305","author":"Andrikos","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0415","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/uog.21949","article-title":"sFlt-1\/PlGF ratio and timing of delivery in early-onset fetal growth restriction with antegrade umbilical artery flow","volume":"56","author":"Quezada","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0420","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/aogs.14546","article-title":"The sFlt1\/PlGF ratio predicts faster fetal deterioration in early fetal growth restriction: a historical cohort study","volume":"102","author":"Palma Dos Reis","year":"2023","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0425","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/1471-0528.17151","article-title":"Angiogenic factors for planning fetal surveillance in fetal growth restriction and small-for-gestational-age fetuses: a prospective observational study","volume":"129","author":"Bonacina","year":"2022","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0430","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3109\/14767058.2015.1048431","article-title":"The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia","volume":"29","author":"Chaiworapongsa","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0435","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.preghy.2018.08.448","article-title":"sFlt-1\/PlGF and Doppler ultrasound parameters in SGA pregnancies with confirmed neonatal birth weight below 10th percentile","volume":"14","author":"Kwiatkowski","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0440","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12884-017-1226-7","article-title":"EVERREST prospective study: a 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction","volume":"17","author":"Spencer","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0445","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/uog.26116","article-title":"Prediction of perinatal survival in early-onset fetal growth restriction: role of placental growth factor","volume":"61","author":"Rodr\u00edguez-Calvo","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0450","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejogrb.2019.11.018","article-title":"Association between the fetal cerebroplacental ratio and biomarkers of hypoxia and angiogenesis in the maternal circulation at term","volume":"245","author":"Irvine","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0455","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.placenta.2014.03.021","article-title":"Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusion","volume":"35","author":"Triunfo","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0460","doi-asserted-by":"crossref","first-page":"618.e1","DOI":"10.1016\/j.ajog.2022.05.043","article-title":"Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction","volume":"227","author":"Agrawal","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0465","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s40814-020-00722-x","article-title":"The PLANES study: a protocol for a randomised controlled feasibility study of the placental growth factor (PlGF) blood test-informed care versus standard care alone for women with a small for gestational age fetus at or after 32 + 0 weeks\u2019 gestation","volume":"6","author":"Gent","year":"2020","journal-title":"Pilot Feasibility Stud"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0470","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/uog.1914","article-title":"Qualitative venous Doppler flow waveform analysis in preterm intrauterine growth-restricted fetuses with ARED flow in the umbilical artery\u2013correlation with short-term outcome","volume":"25","author":"Schwarze","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0475","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ajog.2003.11.028","article-title":"Venous Doppler in the prediction of acid-base status of growth-restricted fetuses with elevated placental blood flow resistance","volume":"191","author":"Baschat","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0480","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/uog.5386","article-title":"Progression of Doppler abnormalities in intrauterine growth restriction","volume":"32","author":"Turan","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0485","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.0960-7692.2002.00627.x","article-title":"Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus","volume":"19","author":"Ferrazzi","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0490","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/uog.17361","article-title":"Fetal monitoring indications for delivery and 2-year outcome in 310 infants with fetal growth restriction delivered before 32 weeks\u2019 gestation in the TRUFFLE study","volume":"50","author":"Visser","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0495","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/uog.13190","article-title":"Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)","volume":"42","author":"Lees","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0500","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/uog.1906","article-title":"Outcome of 60 neonates who had ARED flow prenatally compared with a matched control group of appropriate-for-gestational age preterm neonates","volume":"25","author":"Hartung","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0505","first-page":"527","article-title":"Impact of reverse end-diastolic flow velocity in umbilical artery on pregnancy outcome after the 28th gestational week","volume":"77","author":"Wang","year":"1998","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0510","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c7087","article-title":"Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT)","volume":"341","author":"Boers","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0515","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamapediatrics.2013.2581","article-title":"Adverse neonatal outcomes associated with early-term birth","volume":"167","author":"Sengupta","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0520","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ppul.23529","article-title":"Early-term deliveries as an independent risk factor for long-term respiratory morbidity of the offspring","volume":"52","author":"Walfisch","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0525","doi-asserted-by":"crossref","first-page":"e37452","DOI":"10.2196\/37452","article-title":"The fetal growth restriction at term managed by angiogenic factors versus feto-maternal Doppler (GRAFD) trial to avoid adverse perinatal outcomes: protocol for a multicenter, open-label, randomized controlled trial","volume":"11","author":"Garcia-Manau","year":"2022","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0530","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/uog.26442","article-title":"OC19.03: growth restriction at term: angiogenic factors versus Doppler (GRAFD trial)","volume":"62","author":"Mendoza","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0535","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1159\/000312869","article-title":"What does \u201cnon-inferior to\u201d really mean? A clinician thinking out loud","volume":"29","author":"Ricci","year":"2010","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0540","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0140-6736(07)61604-3","article-title":"Non-inferiority trials are unethical because they disregard patients\u2019 interests","volume":"370","author":"Garattini","year":"2007","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0545","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.semnephrol.2017.05.005","article-title":"Chronic kidney disease and pregnancy","volume":"37","author":"Hladunewich","year":"2017","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0550","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2215\/CJN.09250914","article-title":"A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy","volume":"10","author":"Zhang","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0555","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2215\/CJN.07911109","article-title":"Pregnancy and chronic kidney disease: a challenge in all CKD stages","volume":"5","author":"Piccoli","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0560","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/bmj.39406.652986.BE","article-title":"Chronic kidney disease in pregnancy","volume":"336","author":"Williams","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0565","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/ndt\/gfs573","article-title":"Pre-eclampsia or chronic kidney disease? The flow hypothesis","volume":"28","author":"Piccoli","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0570","first-page":"23","article-title":"sFlt-1 in chronic kidney disease: friend or foe?","author":"Matsui","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0575","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1681\/ASN.2014080772","article-title":"Placental growth factor as a predictor of cardiovascular events in patients with CKD from the NARA-CKD study","volume":"26","author":"Matsui","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0580","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1681\/ASN.2020111579","article-title":"Circulating soluble fms-like tyrosine kinase in renal diseases other than preeclampsia","volume":"32","author":"Wewers","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0585","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0590","doi-asserted-by":"crossref","first-page":"S1019","DOI":"10.1016\/j.ajog.2020.10.022","article-title":"Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders","volume":"226","author":"Rana","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0595","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s40620-022-01299-9","article-title":"Clinical usefulness of angiogenic factors in women with chronic kidney disease and suspected superimposed preeclampsia","volume":"35","author":"Molina-P\u00e9rez","year":"2022","journal-title":"J Nephrol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0600","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ki.2012.348","article-title":"Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers","volume":"83","author":"Rolfo","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0605","article-title":"Is it possible to differentiate chronic kidney disease and preeclampsia by means of new and old biomarkers?","volume":"2015","author":"Rolfo","year":"2015","journal-title":"A Prospective Study Dis Markers"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0610","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000339935","article-title":"Superimposed preeclampsia in women with chronic kidney disease","volume":"74","author":"Masuyama","year":"2012","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0615","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/acr.24360","article-title":"Soluble Flt-1, placental growth factor, and vascular endothelial growth factor serum levels to differentiate between active lupus nephritis during pregnancy and preeclampsia","volume":"73","author":"de Jes\u00fas","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0620","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.kint.2015.10.012","article-title":"Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease","volume":"89","author":"Bramham","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0625","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preghy.2021.02.010","article-title":"Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease","volume":"24","author":"Wiles","year":"2021","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0630","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0028-2243(84)90117-5","article-title":"Doppler assessment of the fetoplacental circulation in normal and growth-retarded fetuses","volume":"18","author":"Reuwer","year":"1984","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0635","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0002-9378(85)90278-9","article-title":"Umbilical artery velocity waveforms and intrauterine growth retardation","volume":"151","author":"Fleischer","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0640","first-page":"649","article-title":"Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies","volume":"68","author":"Campbell","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0645","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.294.6563.13","article-title":"Doppler studies in the growth retarded fetus and prediction of neonatal necrotising enterocolitis, haemorrhage, and neonatal morbidity","volume":"294","author":"Hackett","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0650","first-page":"CD001450","article-title":"Fetal and umbilical Doppler ultrasound in normal pregnancy","author":"Alfirevic","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0655","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/0002-9378(95)90466-2","article-title":"Doppler ultrasonography in high-risk pregnancies: systematic review with meta-analysis","volume":"172","author":"Alfirevic","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0660","first-page":"CD007529","article-title":"Fetal and umbilical Doppler ultrasound in high-risk pregnancies","volume":"6","author":"Alfirevic","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0665","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1469-0705.1994.04020109.x","article-title":"Ductus venosus blood velocity and the umbilical circulation in the seriously growth-retarded fetus","volume":"4","author":"Kiserud","year":"1994","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0670","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.CIR.91.1.129","article-title":"Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Arterial, intracardiac, and venous blood flow velocity studies","volume":"91","author":"Hecher","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0675","doi-asserted-by":"crossref","first-page":"606.e1","DOI":"10.1016\/j.ajog.2017.02.005","article-title":"Is cerebroplacental ratio a marker of impaired fetal growth velocity and adverse pregnancy outcome?","volume":"216","author":"Khalil","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.07.042_b0680","doi-asserted-by":"crossref","first-page":"e055543","DOI":"10.1136\/bmjopen-2021-055543","article-title":"Perinatal and 2-year neurodevelopmental outcome in late preterm fetal compromise: the TRUFFLE 2 randomised trial protocol","volume":"12","author":"Mylrea-Foley","year":"2022","journal-title":"BMJ Open"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121152400397X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121152400397X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:12:05Z","timestamp":1762456325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121152400397X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":136,"alternative-id":["S030121152400397X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.07.042","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does the use of angiogenic biomarkers for the management of preeclampsia and fetal growth restriction improve outcomes?: Challenging the current status quo","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.07.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}